KRAS and breast carcinoma: Furthermore, the florescent labeling analysis results of breast cancer progression revealed that miR-30c binds 3'UTP of KRAS transcripts and silences the expression of KRAS mRNA and protein, which further inhibit the metastasis of breast cancer cells38.